Lower 1,5-anhydroglucitol is associated with adverse clinical events after percutaneous coronary intervention.
Fujiwara T, Yoshida M, Akashi N, Yamada H, Tsukui T, Nakamura T, Sakakura K, Wada H, Arao K, Katayama T, Umemoto T, Funayama H, Sugawara Y, Mitsuhashi T, Kakei M, Momomura S, Ako J.
Fujiwara T, et al. Among authors: tsukui t.
Heart Vessels. 2016 Jun;31(6):855-62. doi: 10.1007/s00380-015-0682-0. Epub 2015 Apr 29.
Heart Vessels. 2016.
PMID: 25921916